Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-05-21 @ 11:13 PM
Study NCT ID:
NCT06908733
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-03
First Post:
2025-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC
Sponsor:
Liaoning Cancer Hospital & Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HURRICANE (LCH-LT04)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None